20-62837219-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001853.4(COL9A3):c.1740T>C(p.Pro580Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.69 in 1,611,778 control chromosomes in the GnomAD database, including 387,113 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.75 ( 43619 hom., cov: 32)
Exomes 𝑓: 0.68 ( 343494 hom. )
Consequence
COL9A3
NM_001853.4 synonymous
NM_001853.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.940
Publications
18 publications found
Genes affected
COL9A3 (HGNC:2219): (collagen type IX alpha 3 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3. [provided by RefSeq, Jan 2010]
COL9A3 Gene-Disease associations (from GenCC):
- epiphyseal dysplasia, multiple, 3Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, G2P, Labcorp Genetics (formerly Invitae)
- Stickler syndromeInheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, ClinGen
- Stickler syndrome, type 6Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- multiple epiphyseal dysplasia due to collagen 9 anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive Stickler syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 20-62837219-T-C is Benign according to our data. Variant chr20-62837219-T-C is described in ClinVar as Benign. ClinVar VariationId is 258417.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.94 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.921 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL9A3 | NM_001853.4 | c.1740T>C | p.Pro580Pro | synonymous_variant | Exon 30 of 32 | ENST00000649368.1 | NP_001844.3 | |
| COL9A3 | XM_047439893.1 | c.1917T>C | p.Pro639Pro | synonymous_variant | Exon 29 of 31 | XP_047295849.1 | ||
| COL9A3 | XM_047439894.1 | c.1179T>C | p.Pro393Pro | synonymous_variant | Exon 30 of 32 | XP_047295850.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.748 AC: 113705AN: 151936Hom.: 43553 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
113705
AN:
151936
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.681 AC: 168289AN: 247034 AF XY: 0.674 show subpopulations
GnomAD2 exomes
AF:
AC:
168289
AN:
247034
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.684 AC: 998414AN: 1459724Hom.: 343494 Cov.: 66 AF XY: 0.681 AC XY: 494259AN XY: 726294 show subpopulations
GnomAD4 exome
AF:
AC:
998414
AN:
1459724
Hom.:
Cov.:
66
AF XY:
AC XY:
494259
AN XY:
726294
show subpopulations
African (AFR)
AF:
AC:
31449
AN:
33476
American (AMR)
AF:
AC:
29847
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
AC:
18552
AN:
26110
East Asian (EAS)
AF:
AC:
23923
AN:
39696
South Asian (SAS)
AF:
AC:
51183
AN:
86244
European-Finnish (FIN)
AF:
AC:
35158
AN:
51570
Middle Eastern (MID)
AF:
AC:
4294
AN:
5746
European-Non Finnish (NFE)
AF:
AC:
762031
AN:
1111822
Other (OTH)
AF:
AC:
41977
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
18836
37672
56507
75343
94179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19458
38916
58374
77832
97290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.749 AC: 113837AN: 152054Hom.: 43619 Cov.: 32 AF XY: 0.742 AC XY: 55166AN XY: 74326 show subpopulations
GnomAD4 genome
AF:
AC:
113837
AN:
152054
Hom.:
Cov.:
32
AF XY:
AC XY:
55166
AN XY:
74326
show subpopulations
African (AFR)
AF:
AC:
38568
AN:
41522
American (AMR)
AF:
AC:
10683
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
2528
AN:
3466
East Asian (EAS)
AF:
AC:
3046
AN:
5134
South Asian (SAS)
AF:
AC:
2739
AN:
4810
European-Finnish (FIN)
AF:
AC:
7200
AN:
10576
Middle Eastern (MID)
AF:
AC:
235
AN:
294
European-Non Finnish (NFE)
AF:
AC:
46672
AN:
67942
Other (OTH)
AF:
AC:
1549
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1431
2862
4293
5724
7155
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
834
1668
2502
3336
4170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2266
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:5
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Epiphyseal dysplasia, multiple, 3 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.